Biospecifics technologies corp (BSTC)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net income

4,498

7,353

6,272

6,426

4,416

6,183

5,043

4,847

3,978

2,644

2,714

2,624

3,344

2,916

3,053

2,572

2,829

2,658

2,870

1,757

2,330

1,919

1,394

577

753

1,725

1,178

1,028

1,353

1,100

471

666

742

71

269

2,569

3,691

Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization

22

111

52

-53

203

448

615

669

699

606

548

539

545

475

399

401

414

285

327

147

172

50

88

63

44

-

-

16

16

20

14

16

12

18

11

10

10

Stock-based compensation expense

500

341

259

118

141

103

63

63

32

26

33

33

33

33

33

33

33

33

33

33

5

5

5

5

5

5

1

79

26

26

26

135

39

126

126

131

133

Deferred tax expense (credit)

88

24

-40

-159

0

-

-

-

-

-1,252

-80

-120

-97

-80

12

-83

2,819

-14

-200

-241

0

-406

8

-25

-5

11

0

17

-18

-855

-203

-155

-260

-3

-52

-435

3,539

Amount of amortization expense for right-of-use asset from operating lease.

18

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

(Accretion) amortization of bond (discount) premium

-132

-

-

-

50

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on the sale of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1

0

0

0

0

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-1,315

1,297

1,039

252

-41

2,063

807

-5,517

6,955

-26

18

-265

1,117

-35

-432

492

1,239

-1,663

1,209

-654

717

-126

1,034

113

-3,072

-40

1,140

993

-2,172

1,876

384

973

-1,389

1,537

822

-138

-970

Income tax payable

-

-

-

-

-

-

-

-1,585

1,067

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax payable

-1,285

-

-

-

-1,097

-

-

-

-

-125

-233

7

-212

494

-884

-44

12

-257

466

69

-13

-98

-521

978

38

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

71

129

-175

407

-42

-155

-35

256

-42

-49

-127

216

-40

69

-176

263

83

-11

-193

285

44

-

-

-

-

-117

33

47

214

162

-38

-141

69

-158

164

70

-11

Investment interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12

7

-10

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

91

-36

1

-

-

-

-

-

-

-

-

-

-

-

-

Patent costs

12

36

97

92

0

25

15

34

44

204

0

0

0

0

12

5

5

1

6

17

0

12

34

0

151

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

630

118

166

-1,233

146

682

-533

-130

308

148

-377

1

422

-253

404

-50

26

-40

-180

47

239

26

-201

-157

242

35

-61

-105

253

-103

20

-1,838

1,833

-176

-942

-1,442

-447

The increase (decrease) during the reporting period in the carrying amount lease obligations.

11

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

0

0

-135

-4

-291

-270

-377

-259

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued taxes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49

332

-

-

102

0

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-286

-284

8,237

87

-12

-12

-12

-12

-12

-17

-17

-17

-26

-44

-44

-44

-109

-109

-109

-109

-109

-109

-155

Net cash provided by operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,382

-

1,750

2,497

1,987

2,155

614

-565

3,925

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by operating activities

8,219

7,746

4,707

3,790

6,039

5,456

4,189

8,960

-876

3,785

3,071

2,981

3,319

-

-

-

-

-

-

-

-

-

-

-

-

-

-449

-35

3,913

-

177

-1,702

4,099

-1,445

-1,578

1,662

674

Cash flows from investing activities:
Purchases of property and equipment

69

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of marketable investments

35,263

16,432

34,184

22,299

20,152

16,790

21,101

16,992

20,287

10,741

10,723

14,638

18,217

10,694

10,845

9,469

12,233

3,027

2,740

3,104

5,197

1,631

1,203

2,605

2,206

1,920

3,360

1,230

3,200

70

3,000

0

2,000

0

5,360

0

0

Purchases of marketable investments

29,058

31,744

40,253

31,274

21,829

22,010

24,022

26,278

14,318

13,753

13,264

20,364

17,304

12,366

18,634

13,765

15,169

9,757

7,489

9,589

7,343

6,004

1,205

2,425

3,213

2,160

2,120

4,234

3,042

0

3,190

0

2,000

0

5,000

0

0

Proceeds from sale of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

1

0

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by (used in) investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,935

-

-4,748

-6,485

-2,145

-4,373

-1

180

-1,004

-

-

-

-

-

-

-

-

-

-

-

-

Payment for royalty buy down

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,500

0

0

0

0

Net cash provided by (used in) investing activities

6,136

-15,312

-6,068

-8,975

-1,677

-5,219

-2,921

-9,286

5,968

-3,011

-2,541

-5,726

912

-

-

-

-

-

-

-

-

-

-

-

-

-

1,240

-3,004

157

-

-190

0

-1,500

0

360

0

0

Cash flows from financing activities:
Proceeds from stock option exercises

0

58

396

1,678

58

0

1,710

727

132

137

0

0

258

182

352

0

177

9

1,141

1,635

37

1,942

35

102

66

20

10

0

0

0

70

0

78

0

10

72

0

Payments for repurchase of common stock

221

263

238

118

0

-

-

-

-

0

137

256

221

150

205

293

398

620

480

586

114

79

0

669

80

66

211

190

205

360

188

287

198

379

154

206

0

Excess tax benefits from share-based payment arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

78

72

0

151

619

1,278

751

1,158

454

222

857

404

-

-

-

-

-5

165

-0

102

1,225

137

346

0

Net cash provided by (used in) financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-70

-

1,938

1,800

1,081

2,317

258

291

389

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used in) provided by financing activities

-221

-204

157

1,559

58

-441

-848

727

132

137

-137

-256

36

-

-

-

-

-

-

-

-

-

-

-

-

-

-201

-190

-205

-

47

-287

-18

846

-6

212

0

Increase in cash and cash equivalents

14,135

-7,770

-1,203

-3,624

4,420

-204

420

401

5,225

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

911

392

-3,001

4,268

15

-2,216

-2,550

4,376

-2,350

-1,059

-2,186

923

99

870

-94

3,309

1,017

589

-3,230

3,864

-440

35

-1,989

2,581

-598

-1,224

1,875

674

Cash paid during the year for [Abstract]
Interest

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Taxes

16

830

2,636

1,819

7

1,500

1,300

2,617

0

990

1,640

1,310

1,460

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

535

1,210

4,080

-

466

0

80

0

0

400

15

935

890

510

378

70

70

92

0

0

190

0

0